Stunning deal and any new buyer gets to participate in the upcoming share/option offer that are already in the money. How good is that.
the deal itself is beneficial to both parties:The Terms Of The Deal
The high-level terms of the deal are as follows:
- PointsBet will become the official sports betting partner of NBC Sports in the US;
- This media-partnership has an initial term of 5 years;
- PointsBet will commit to spending US$393m (~A$540m) in marketing expenses on NBC’s US media channels over the next 5 years;
- This cost will be offset by NBC buying a 4.9% stake in PointsBet at $6.50 per share (NBC will be issued new shares). Based on the current share count, that would amount to ~A$49m but it may end up being higher as more PointsBet shares are issued;
- The marketing cost will also be further offset by NBC buying 66.88m options to buy more PointsBet shares. These options have a 5-year term and are exercisable at a price of A$13 per share;
- If all the options are exercised on a cash settlement basis, the company would receive further funding of ~A$870m. In such a scenario, the bulk of this would be offsetting company’s marketing costs;
- NBC may elect not to exercise the options, in which case they would receive a refund on the current options’ value of ~A$105m. This would likely happen if, after 5 years, the PointsBet share price is trading below the options exercise price of $13;
- PointsBet will simultaneously undertake a rights offer which could raise up to $300m in funding.
- Forums
- ASX - By Stock
- Amazing deal with NBC
PBH
pointsbet holdings limited
Add to My Watchlist
0.00%
!
$1.19

Stunning deal and any new buyer gets to participate in the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $393.0M |
Open | High | Low | Value | Volume |
$1.19 | $1.19 | $1.18 | $682.8K | 576.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 400159 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 33022 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 400159 | 1.185 |
7 | 680520 | 1.180 |
6 | 270394 | 1.175 |
1 | 3996 | 1.170 |
1 | 8700 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 33022 | 2 |
1.195 | 309824 | 7 |
1.200 | 535963 | 18 |
1.205 | 45000 | 3 |
1.210 | 221 | 1 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
PBH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online